Business Standard

Suven Pharmaceuticals Share Price

Know More
BSENSE

1,238.25-20.80 (-1.65%)

04:01 PM, 18-Dec-2024

1,246.45-19.30 (-1.52%)

03:46 PM, 18-Dec-2024

BSE : 543064

NSE : SUVENPHAR

Sector : Health care

ISIN Code : INE03QK01018

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 18-Dec-2024 | 04:01 PM IST

Market Cap (₹ Cr)

31,526

Traded Value (₹ Cr)

1.08

Volume (Shares)

8,722

Face Value (₹)

1

52-Week High (₹)

1,359.00

52-Week High Date

02-Dec-2024

52-Week Low (₹)

586.10

52-Week Low Date

06-Feb-2024

All Time High (₹)

1,359.00

All Time High Date

02-Dec-2024

All Time Low (₹)

87.05

All Time Low Date

24-Mar-2020

Suven Pharmaceuticals Ltd

Suven Pharmaceuticals Limited (SPL) is a bio-pharmaceutical company incorporated on 6th November 2018 and is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates Active Pharmaceutical Ingredients (API) Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical biotechnology and chemical companies. The Company is a CDMO that supports global life sciences industry and fine chemical majors in their NCE development endeavors. Its services include custom synthesis process R&D scale-up and contract manufacturing of intermediates APIs and formulations. Suven Pharma Inc. a Delaware Compan...
Read More

Suven Pharma News

Suven Pharma shares jump 6% after topline zooms 11% in Q2 earnings

3 min read

Suven, Cohance aim to double combined biz revenue to Rs 6,000 cr by FY29

2 min read

Suven Pharma hits record high on USFDA's 'VAI' tag to Hyderabad facility

3 min read

Suven Pharma, Max Health can rally up to 9%: Angel One

3 min read

Sensex, Nifty fall for third day as FPIs pull funds ahead of Fed meet

4 min read
More

Suven Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

31,735

EPS - TTM (₹) [C]

9.55

P/E Ratio (X) [C]

130.52

Face Value (₹) 1
Latest Dividend (%)100.00
Latest Dividend Date 09-Sep-2022
Dividend Yield (%) -
Book Value Share (₹) [C]77.71
P/B Ratio (₹) [C]16.04

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
DSP Healthcare Fund (G) 325.08 24,89,539 10.01
DSP Healthcare Fund (IDCW) 325.08 24,89,539 10.01
DSP Healthcare Fund - Direct (G) 325.08 24,89,539 10.01
DSP Healthcare Fund - Direct (IDCW) 325.08 24,89,539 10.01
DSP ELSS Tax Saver Fund (G) 318.83 24,41,631 1.89
DSP ELSS Tax Saver Fund (IDCW) 318.83 24,41,631 1.89
DSP ELSS Tax Saver Fund - Direct (IDCW) 318.83 24,41,631 1.89
DSP ELSS Tax Saver Fund - Direct (G) 318.83 24,41,631 1.89
HSBC Small Cap Fund (G) 300.08 22,98,085 1.74
HSBC Small Cap Fund (IDCW) 300.08 22,98,085 1.74

Load more

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

1,237.00

1,284.00

Week Low/High (₹)

1,220.05

1,310.00

Month Low/High (₹)

1,220.05

1,360.00

Year Low/High (₹)

585.20

1,360.00

All time Low/High (₹)

87.05

1,360.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-3.89%-3.88%-1.65-1.80%
1 Month-2.91%-2.70%3.683.18%
3 Month8.87%8.88%-3.33-4.64%
6 Month66.89%66.54%3.732.72%
1 Year79.95%79.45%12.4312.98%
3 Year158.12%158.57%40.6442.47%

Company Info

Company Information

Non Executive Director : Shweta Jalan

Independent Director : U B Pravin Rao

Managing Director : Venkatanaga Kali Vara Prasad Raju Vetukuri

Non Executive Director : Pankaj Patwari

Independent Director : Matangi Gowrishankar

Independent Director : Vinod Rao

Independent Director : K G Ananthakrishnan

Executive Chairman & Director : VIVEK SHARMA

Company Sec. & Compli. Officer : Kundan Kumar Jha

Additional Director : Jaishankar Krishnan

Additional Director : Vinod Padikkal

Registered Office: 8-2-334 SDE Serene Chambers, 3 Floor Avenue 7 Road No 5,Hyderabad,Telangana-500034 Ph: 91-40-23549414/1142/3311

Email:khrao@suvenpharm.com

URL:http://www.suvenpharm.com

FAQs about Suven Pharmaceuticals Ltd

1. What's the Suven Pharmaceuticals Ltd share price today?
Suven Pharmaceuticals Ltd share price was Rs 1,238.25 at 04:01 PM IST on 18th Dec 2024. Suven Pharmaceuticals Ltd share price was down by 1.65% from the previous closing price of Rs 1,259.05. Suven Pharmaceuticals Ltd share price trend:

  • Last 1 Month: Suven Pharmaceuticals Ltd share price moved down by 2.91% on BSE
  • Last 3 Months: Suven Pharmaceuticals Ltd share price moved up by 8.87% on BSE
  • Last 12 Months: Suven Pharmaceuticals Ltd share price moved up by 79.95% on BSE
  • Last 3 Years: Suven Pharmaceuticals Ltd price moved up by 158.12% on BSE


2. How can I quickly analyse the performance of the Suven Pharmaceuticals Ltd stock?
The performance of the Suven Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 130.52
  • Price to book value ratio is 16.04
  • Dividend yield of 0.00
  • The EPS (trailing 12 months) of the Suven Pharmaceuticals Ltd stock is Rs 9.55


3. What is the market cap of Suven Pharmaceuticals Ltd?
Suven Pharmaceuticals Ltd has a market capitalisation of Rs 31,526 crore.


4. What is Suven Pharmaceuticals Ltd's 52-week high/low share price?
The Suven Pharmaceuticals Ltd’s 52-week high share price is Rs 1,359.00 and 52-week low share price is Rs 586.10.


5. Is the Suven Pharmaceuticals Ltd profitable?
On a consolidated basis, Suven Pharmaceuticals Ltd reported a profit of Rs 76.33 crore on a total income of Rs 249.49 crore for the quarter ended 2024. For the year ended Sep 2024, Suven Pharmaceuticals Ltd had posted a profit of Rs 81.98 crore on a total income of Rs 271.84 crore.


6. Which are Suven Pharmaceuticals Ltd’s peers in the Health care sector?
Suven Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Ipca Labs., Ajanta Pharma, Piramal Pharma, Suven Pharma, Laurus Labs, Gland Pharma, J B Chemicals &.


7. Who owns how much in Suven Pharmaceuticals Ltd?
Key changes to the Suven Pharmaceuticals Ltd shareholding are as follows:

  • Promoter holding in Suven Pharmaceuticals Ltd has gone down to 50.10 per cent as of Sep 2024 from 60.00 per cent as of Dec 2023.